Modulation of Hepatic Inflammatory Risk Markers of Cardiovascular Diseases by PPAR- Activators: Clinical and Experimental Evidence
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000204327.96431.9a
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2006
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)